URGN UroGen Pharma Ltd.
2026Q1 · CUSIP M96088105 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
171
Δ holders QoQ
+3
Breadth percentile
Top 50%
Whale holders
88
Δ whales
+2
Inst. holding value
$835M
New positions
33
Closed positions
30
Price momentum (1Q)
—
Put / Call
3/4
Breadth history (34 quarters)
Past Lit Events & Aftermath 5 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2023Q3 | Top 11% | — | — |
| 2023Q2 | Top 11% | — | — |
| 2019Q2 | Top 19% | — | — |
| 2018Q3 | Top 20% | — | — |
| 2018Q2 | Top 16% | — | — |
Options Sentiment
Put holders
3
QoQ: 0
Call holders
4
QoQ: -2
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-2.74
EPS YoY
—
Revenue (TTM)
$0.1B
Revenue YoY
+52.9%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)